Impaired post-infarction cardiac remodeling in chronic kidney disease is due to excessive renin release

[1]  Akshay S. Desai,et al.  Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction. , 2011, European heart journal.

[2]  P. McCullough,et al.  Cardiorenal syndromes. , 2011, World journal of cardiology.

[3]  C. Ronco,et al.  ADPKD: Prototype of Cardiorenal Syndrome Type 4 , 2010, International journal of nephrology.

[4]  P. McCullough.  Cardiorenal Syndromes: Pathophysiology to Prevention , 2010, International journal of nephrology.

[5]  P. McCullough.  Prevention of cardiorenal syndromes. , 2010, Contributions to nephrology.

[6]  Hongli,et al.  Upregulation of Nox4 by Hypertrophic Stimuli Promotes Apoptosis and Mitochondrial Dysfunction in Cardiac Myocytes , 2010 .

[7]  M. Isobe,et al.  The Mechanism of Anti-Inflammatory Effects of Prostaglandin E2 Receptor 4 Activation in Murine Cardiac Transplantation , 2009, Transplantation.

[8]  S. Solomon,et al.  Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  G. Bakris,et al.  Novel therapies of diabetic nephropathy , 2009, Current opinion in nephrology and hypertension.

[10]  C. Tschöpe,et al.  Renin Inhibition Improves Cardiac Function and Remodeling After Myocardial Infarction Independent of Blood Pressure , 2008, Hypertension.

[11]  N. Hollenberg,et al.  Renal and Hormonal Responses to Direct Renin Inhibition With Aliskiren in Healthy Humans , 2008, Circulation.

[12]  M. Isobe,et al.  Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation. , 2008, Journal of the American College of Cardiology.

[13]  R. Charnigo,et al.  Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. , 2008, The Journal of clinical investigation.

[14]  H. Paulson,et al.  SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. , 2008, The Journal of clinical investigation.

[15]  Simon J. Walker,et al.  Involvement of Nox2 NADPH Oxidase in Adverse Cardiac Remodeling After Myocardial Infarction , 2008, Hypertension.

[16]  M. Fukayama,et al.  Periostin is essential for cardiac healing after acute myocardial infarction , 2008 .

[17]  A. Hall,et al.  Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction: Unraveling the ARB-MI Paradox , 2006, Circulation.

[18]  D. Sorescu,et al.  NAD(P)H Oxidase 4 Mediates Transforming Growth Factor-β1–Induced Differentiation of Cardiac Fibroblasts Into Myofibroblasts , 2005, Circulation research.

[19]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[20]  W. Kuziel,et al.  Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. , 2004, The American journal of pathology.

[21]  Alice Stanton,et al.  Structure-based design of aliskiren, a novel orally effective renin inhibitor. , 2003, Biochemical and biophysical research communications.

[22]  Y. Quiroz,et al.  Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. , 2003, Kidney international.

[23]  A. Takeshita,et al.  Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction , 2002, Circulation.

[24]  C. Enwemeka,et al.  A simplified method for the analysis of hydroxyproline in biological tissues. , 1996, Clinical biochemistry.

[25]  Masaki Sugiura,et al.  Angiotensin II Type 1a Receptor-deficient Mice with Hypotension and Hyperreninemia (*) , 1995, The Journal of Biological Chemistry.

[26]  A. Fukamizu,et al.  Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. , 1993, The Journal of biological chemistry.